Similarly, 11 immune-related lncRNA signatures have been identified in glioma patients: H19, DLGAP1.AS1, AC025171.1, PAXIP1.AS2, FEZF1.AS1, HOTAIRM1, HOXD.AS2, and ARHGEF26.AS1 are upregulated and LINC00205, WDR11.AS1, and THAP7.AS1 are downregulated in a high-risk glioma group compared to a low-risk group [148, 149]. The gene discussed is DLGAP1; the disease is central nervous system cancer.